LCO Capital Healthcare Fund I, LP
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$11M
Investors
57
Min Invest
$50,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
LCO Capital Healthcare Fund I, LP is a Delaware limited partnership that first filed a Form D on January 4, 2022 and most recently amended it on January 4, 2023, describing itself as a private equity fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(1) and covers pooled investment fund interests. LCO Capital Healthcare Fund I, LP reported $10,820,000 sold from 57 investors of a $50,000,000 total offering as of the Form D filed January 4, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000. The Form D names JONATHAN NANCE (CRD 137918), associated with None as the recipient of sales compensation soliciting in all states. The issuer's address of record is 5301 Newstead Manor Lane, Raleigh, NC 27606.
Critical Disclosures
What the filings and the regulators have said about this entity that a reader should know first. Each line links to its source. The history, the same event across other issuers, and alerts are in the terminal.
Reporting lapsed · Form D · last filing January 4, 2023
Offering declared to continue beyond a year; annual amendment 13+ months overdue An issuer that stops filing is the case the going-concern flag cannot catch: the report that would have carried it was never filed.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
dark
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
LCO CAPITAL PARTNERS, LLC
Director · RALEIGH, NC
GENERAL PARTNER OF THE ISSUER
LCO CAPITAL MANAGEMENT, LLC
Director · RALEIGH, NC
INVESTMENT MANAGER OF THE ISSUER
KEVIN SCHIMELFENIG
Executive Officer · RALEIGH, NC
MANAGER OF THE GENERAL PARTNER OF THE ISSUER
KYLE SCHIMELFENIG
Director · CLAYTON, NC
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
JONATHAN NANCECRD 137918 on BrokerCheck
Associated broker-dealer: None · CHARLOTTE, NC · Soliciting in all states
Questions About LCO Capital Healthcare Fund I, LP
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is LCO Capital Healthcare Fund I, LP?
LCO Capital Healthcare Fund I, LP is a Delaware limited partnership that filed a Form D with the SEC on January 4, 2023 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of pooled investment fund interests.
Is LCO Capital Healthcare Fund I, LP legit?
AltStreet does not rate legitimacy; it reports the public record. LCO Capital Healthcare Fund I, LP filed a Form D with the SEC on January 4, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $10,820,000 sold to 57 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is LCO Capital Healthcare Fund I, LP registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that LCO Capital Healthcare Fund I, LP claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has LCO Capital Healthcare Fund I, LP raised?
LCO Capital Healthcare Fund I, LP reported $10,820,000 sold from 57 investors of a $50,000,000 total offering as of the Form D filed January 4, 2023.
Who can invest in LCO Capital Healthcare Fund I, LP?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $50,000.
What is the minimum investment in LCO Capital Healthcare Fund I, LP?
The Form D lists $50,000 as the minimum investment accepted from any outside investor as of January 4, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling LCO Capital Healthcare Fund I, LP and how are they paid?
The Form D names JONATHAN NANCE (CRD 137918), associated with None as the recipient of sales compensation soliciting in all states.
Who is behind LCO Capital Healthcare Fund I, LP?
The Form D lists 4 related persons: LCO CAPITAL PARTNERS, LLC, director (GENERAL PARTNER OF THE ISSUER); LCO CAPITAL MANAGEMENT, LLC, director (INVESTMENT MANAGER OF THE ISSUER); KEVIN SCHIMELFENIG, executive officer (MANAGER OF THE GENERAL PARTNER OF THE ISSUER); KYLE SCHIMELFENIG, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is LCO Capital Healthcare Fund I, LP located?
The issuer's address on its SEC filings is 5301 Newstead Manor Lane, Raleigh, NC 27606. Its phone number of record is 919-830-0411. It is organized under the laws of Delaware.
How long is the LCO Capital Healthcare Fund I, LP offering open?
The issuer indicated that the offering is intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
How large is LCO Capital Healthcare Fund I, LP?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.